Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Integra LifeSciences
ISIN US4579852082
|WKN 897013
Market cap (in EUR)
930 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Healthcare Healthcare Equipment Other Medical Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 930 m |
| EPS, EUR | -5.58 |
| P/B ratio | 1.0 |
| P/E ratio | 63.6 |
| Dividend yield | 0.00% |
Income statement (2025)
| Revenue, EUR | 1,450 m |
| Net income, EUR | -458 m |
| Profit margin | -31.58% |
What ETF is Integra LifeSciences in?
There is 1 ETF which contains Integra LifeSciences.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares S&P SmallCap 600 UCITS ETF | 0.04% | Equity United States Small Cap | 2,555 |
Latest articles
— Les données utilisées sont mises à disposition par Trackinsight, etfinfo, Xignite Inc., gettex, FactSet et justETF GmbH. Les cotations sont des cotations en temps réel (gettex), des cotations boursières retardées de 15 minutes ou des VNI (quotidiennes publiées par le fournisseur du fonds). Par défaut, les rendements des ETF incluent les paiements de dividendes (le cas échéant). Aucune garantie n'est donnée quant à l'exhaustivité, la précision et l'exactitude des informations affichées.